Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
Beyond Air (XAIR) will participate in the 2026 Cantor Global Healthcare Conference at the Waldorf Astoria New York from September 9-11, 2026.
Rhea-AI Summary
Beyond Air (XAIR) will participate in the 2026 Cantor Global Healthcare Conference at the Waldorf Astoria New York from September 9-11, 2026.
The company’s fireside chat is scheduled for Thursday, September 10 at 3:55 PM EDT, with a live webcast and a 90-day replay available in the Events section of its website.
Positive
- None.
Negative
- None.
Market Reaction – XAIR
Following this news, XAIR has gained 2.73%, reflecting a moderate positive market reaction. Argus tracked a peak move of +3.1% during the session. Our momentum scanner has triggered 8 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $3.76. Trading volume is exceptionally heavy at 7.0x the average, suggesting very strong buying interest.
Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 31 | Breakthrough Device designation | Positive | -11.4% | FDA granted Breakthrough Device Designation for LungFit GO in NTM-PD. |
| Aug 25 | NeuroNOS stake sale | Positive | +1.4% | UNIVO agreed to acquire NeuroNOS control for equity and milestone payments. |
| Aug 13 | Quarterly earnings report | Positive | +14.4% | Revenue guidance was reaffirmed alongside improved gross margin and post-quarter financing. |
| Aug 04 | Earnings scheduling notice | Neutral | -2.4% | Company scheduled quarterly results and an accompanying conference call for August 13. |
| Jul 30 | Private placement offering | Negative | -1.6% | Private placement included common stock, pre-funded warrants and additional purchase warrants. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent reactions were mixed: positive announcements sometimes aligned with gains but also produced notable negative divergences.
Key Terms
nitric oxide technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
GARDEN CITY, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that its management team will participate in the 2026 Cantor Global Healthcare Conference, which is being held at the Waldorf Astoria New York, New York on September 9-11, 2026.
Fireside Chat Details:
Date: Thursday, September 10th
Time: 3:55 PM EDT
Webcast Link: A live webcast of the fireside chat will be available on the Events section of the Company’s website, https://www.beyondair.net/news-events/events. Following the live presentation, a replay of the webcast will be available on the Company's website for 90 days.
If you are interested in requesting a one-on-one meeting at the conference, please contact your Cantor representative to schedule accordingly.
About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.
CONTACTS:
Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577
